ACTRN12608000461392已完成未知
Clinical Trial of a Selective Estrogen Receptor Modulator (raloxifene) in the treatment of cognitive deficits and psychotic symptoms of patients with schizophrenia
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 55 Years（—）
- 性别
- All
入选标准
- •Male and female patients with schizophrenia between the ages of 18 and 45 who have been receiving any antipsychotic medication for at least one year can participate.
排除标准
- •Any patients with a psychiatric diagnosis other than schizophrenia or a history of substance dependence (within past 5 years), head injuries with loss of consciousness, seizures, central nervous system infection, diabetes, hypertension, lactose intolerance, superficial thrombophlebitis (pain and inflammation in a vein just under the skin), thromboembolic disease (blood clotting disease), congestive heart failure, or who have had reactions to raloxifene will be excluded.
研究者
相似试验
已完成
不适用
Efficacy of selective estrogen receptor modulator in pegylated interferon alpha plus ribavirin treatment for menopausal women with chronic hepatitis C womeMenopausal women with chronic hepatitis CJPRN-UMIN000005815Department of General Internal Medicine, Kyushu University Hospital120
尚未招募
2 期
The effectiveness of topical Estradiol, Vaginal Dilators or a combination of both in preventing vaginal stenosis after Radiotherapy for the treatment of cervical cancerOther noninflammatory disorders of vaginaE02.186.775MenopauseRBR-2258hp5niversidade Estadual de Campinas
尚未招募
Unknown
Evaluating utility of Oestrogen and Progesterone Receptor biomarkers for prediction of colorectal CancerCTRI/2024/05/068054Datta Meghe Institute of Higher Education & Research (DMIHER)
进行中（未招募）
1 期
Vaginal administration of selective estrogen receptor modulator (Tamoxifen) treatment to improve sexual function for women with breast cancer. A randomized, double-blinded, placebo controlled longitudinal phase 3 study.Most troublesome vulvovaginal atrophy symptomEUCTR2021-004536-28-SEppsala University, Department of Women's and Children´s Health120
已完成
不适用
Hormonal therapy resistant estorgen receptor positive metastatic breast cancer cohort studyBreast cancerJPRN-UMIN000019556General Incorporated Association of CSPOR-BC200